Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Ally Financial
ALLY
5
Louisiana-Pacific
LPX
US OptionsDetailed Quotes
PCVX250516P60000
- 3.70
- 0.000.00%
15min DelayTrading Mar 25 15:30 ET
0.00High0.00Low
0.00Open3.70Pre Close0 Volume0 Open Interest60.00Strike Price0.00Turnover0.00%IV-77.57%PremiumMay 16, 2025Expiry Date28.30Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.14Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Vaxcyte Newsroom
TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating, Cuts Target Price to $85
Needham Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $90
Optimistic Outlook for Vaxcyte's Vaccines Drives Buy Rating
Cantor Fitzgerald Initiates Vaxcyte(PCVX.US) With Buy Rating
TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $135
Needham Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $90
Vaxcyte Price Target Maintained With a $90.00/Share by Needham
Vaxcyte Analyst Ratings
Leerink Partners Maintains Vaxcyte(PCVX.US) With Buy Rating, Cuts Target Price to $65
Goldman Sachs Maintains Vaxcyte(PCVX.US) With Buy Rating, Cuts Target Price to $100
Optimistic Buy Rating for Vaxcyte Amid Vaccine Development Challenges and Strategic Adjustments
Vaxcyte Is Maintained at Buy by Goldman Sachs
Vaxcyte Price Target Cut to $100.00/Share From $138.00 by Goldman Sachs
B of A Securities Maintains Buy on Vaxcyte, Lowers Price Target to $137
Vaxcyte Is Maintained at Buy by Needham
Vaxcyte Analyst Ratings
Vaxcyte's Strong Phase 2 Data and Future Prospects Justify Buy Rating Despite Market Overreaction
Needham Cuts Price Target on Vaxcyte to $90 From $140, Maintains Buy Rating
Mizuho Securities Maintains Vaxcyte(PCVX.US) With Buy Rating
Guggenheim Maintains Vaxcyte(PCVX.US) With Buy Rating, Raises Target Price to $160
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call